1. Savvidou MD, Sotiriadis A, Kaihura C, Nicolaides KH, Sattar N. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clin Sci (Lond) 2008; 115: 219-224. [
DOI:10.1042/CS20070409]
2. Nakatsukasa H, Masuyama H, Takamoto N, Hiramatsu Y. Circulating leptin and angiogenic factors in preeclampsia patients. Endocr J 2008; 55: 565-573. [
DOI:10.1507/endocrj.K07E-136]
3. Mohaupt M. Molecular aspects of preeclampsia. Mol Aspects Med 2007; 28: 169-191. [
DOI:10.1016/j.mam.2007.02.005]
4. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvas Res 2008; 75: 1-8. [
DOI:10.1016/j.mvr.2007.04.009]
5. Lu D, Yang X, Wu Y, Wang H, Huang H, Dong M. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet 2006; 95: 121-126. [
DOI:10.1016/j.ijgo.2006.06.015]
6. Ouyang YQ, Li SJ, Zhang Q, Xiang WP, Shen HL, Chen HP, et al. Plasma sFlt-1-to-PlGF ratio is correlated with inflammatory but not with oxidative stress in Chinese preeclamptic women. Arch Gynecol Obstet 2009; 280: 91-97. [
DOI:10.1007/s00404-008-0874-2]
7. Ouyang Y, Chen H, Chen H. Reduced plasma adiponectin and elevated leptin in pre-eclampsia. Int J Gynaecol Obstet 2007; 98: 110-114. [
DOI:10.1016/j.ijgo.2007.04.021]
8. Hung JH. Oxidative Stress and Antioxidants in Preeclampsia. J Chin Med Assoc 2007; 70: 430-432. [
DOI:10.1016/S1726-4901(08)70032-7]
9. Dordević NZ, Babić GM, Marković SD, Ognjanović BI, Stajn AS, Zikić RV, et al. Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women. Reprod Toxicol 2008; 25: 213-218. [
DOI:10.1016/j.reprotox.2007.11.001]
10. Haque SK, Siddiqui MU, Islam N, Moin S. Erythrocyte markers of oxidative stress in higher age-group preeclamptic and normal pregnant mothers. Hypertens Pregnancy 2010; 29: 69-81. [
DOI:10.3109/10641950902849868]
11. Aydin S, Guzel SP, Kumru S, Aydin S, Akin O, Kavak E, et al. Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy and preeclamptic pregnant women. J Physiol Biochem 2008; 64: 51-59. [
DOI:10.1007/BF03168234]
12. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-a, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007; 58: 21-30. [
DOI:10.1111/j.1600-0897.2007.00486.x]
13. Khosrowbeygi A, Zarghami N. Levels of oxidative stress biomarkers in seminal plasma and their relationship with seminal parameters. BMC Clin Pathol 2007; 7: 6. [
DOI:10.1186/1472-6890-7-6]
14. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278. [
DOI:10.1016/0003-2697(78)90342-1]
15. Daly LE, Bourke GJ. Interpretation and uses of medical statistics, 5th Ed. Indianapolis; Wiley-Blackwell; 2000. [
DOI:10.1002/9780470696750]
16. Harsem NK, Braekke K, Staff AC. Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 128: 209-215. [
DOI:10.1016/j.ejogrb.2005.11.014]
17. Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, et al. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Orhan free Radic Res 2004; 38: 913-918. [
DOI:10.1080/10715760412331273421]
18. Orhan HG, Ozgüneş H, Beksaç MS. Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. Clin Biochem 2001; 34: 505-506. [
DOI:10.1016/S0009-9120(01)00238-7]
19. Madazli R, Benian A, Aydin S, Uzun H, Tolun N. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J Obstet Gynaecol 2002; 22: 477-480. [
DOI:10.1080/0144361021000003573]
20. Chamy VM, Lepe J, Catalán A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res 2006; 39: 229-236. [
DOI:10.4067/S0716-97602006000200005]
21. Noyan T, Güler A, Sekeroğlu MR, Kamaci M. Serum advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia. Aust N Z J Obstet Gynaecol 2006; 46: 486-491. [
DOI:10.1111/j.1479-828X.2006.00647.x]
22. Adiga U, D'souza V, Kamath A, Mangalore N. Antioxidant activity and lipid peroxidation in preeclampsia. J Chin Med Assoc 2007; 70: 435-438. [
DOI:10.1016/S1726-4901(08)70034-0]
23. Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2006; 94: 23-27. [
DOI:10.1016/j.ijgo.2006.03.025]
24. Biri A, Bozkurt N, Gunaydin G, Korucuoglu U, Durak I, Kavutcu M. Antioxidant enzyme activities and lipid peroxidation in preeclampsia. Int J Gynaecol Obstet 2007; 96: 196-197. [
DOI:10.1016/j.ijgo.2006.10.011]
25. Mehendale S, Kilari A, Dangat K, Taralekar V, Mahadik S, Joshi S. Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int J Gynaecol Obstet 2008; 100: 234-238. [
DOI:10.1016/j.ijgo.2007.08.011]
26. Patil SB, Kodliwadmath MV, Kodliwadmath M. Lipid peroxidation and antioxidant activity in complicated pregnancies. Clin Exp Obstet Gynecol 2009; 36: 110-112.
27. Bowen RS, Moodley J, Dutton MF, Theron AJ. Oxidative stress in pre-eclampsia. Acta Obstet Gynecol Scand 2001; 80: 719-725. [
DOI:10.1034/j.1600-0412.2001.080008719.x]
28. Regan CL, Levine RJ, Baird DD, Ewell MG, Martz KL, Sibai BM, et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001; 185: 572-578. [
DOI:10.1067/mob.2001.116754]
29. Naruse K, Yamasaki M, Umekage H, Sado T, Sakamoto Y, Morikawa H. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol 2005; 65: 65-75. [
DOI:10.1016/j.jri.2004.09.004]
30. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 2000; 28: 1745-1750. [
DOI:10.1016/S0891-5849(00)00232-X]
31. Roberts LJ, Morrow JD: Measurement of F (2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505-513. [
DOI:10.1016/S0891-5849(99)00264-6]
32. Pratico D, Lawson JA, Rokach J, FitzGerald GA: The isoprostanes in biology and medicine. Trends Endocrinol Metab 2001; 12: 243-247. [
DOI:10.1016/S1043-2760(01)00411-8]
33. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294: 541-550. [
DOI:10.1152/ajpheart.01113.2007]